Tag: Glenmark

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It is a research driven global pharmaceutical organization focused on discovering novel molecules and developing high-quality generics and specialty products for markets across the globe. Glenmark has 17 manufacturing facilities across 5 countries including US, Argentina, Czech Republic and India. Glenmark has 5 R&D centers around the world engaged in discovery of novel biological and chemical entities.

Glenmark Launches New Company in USA

The new innovation company will house the current innovative pipeline of 8 assets (NBEs & NCEs), which includes 5 clinical and 3 pre-clinical assets; and innovation-related R&D centres, manufa...

FDA Approval for Glenmark’s Generic

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic vers...

Swiss and China Companies Entered into Agreement

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agre...

Glenmark unveiled new data from trial of its bispecific antibody

Glenmark announced the presentation of new data from the Phase 1 trial of GBR 1302, a HER2xCD3 bispecific antibody, at the European Society for Medical Oncology Immuno-Oncology Congress 2018.

Glenmark launches its first manufacturing site in the U.S.

Glenmark Pharmaceuticals, a global pharmaceutical company, announced the official inauguration of its manufacturing site in Monroe (North Carolina, USA).

Glenmark signs license agreement with Harbour Med

Glenmark Pharmaceuticals S.A. and Harbour BioMed announced that they have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302,

Glenmark Pharma launched its asthma drug generic in Denmark

Glenmark Pharmaceuticals Europe has launched a generic version of Seretide Accuhaler, used to treat asthma, in Denmark. The product was developed by Celon Pharma.

Glenmark entered exclusive agreement with Cyndea Pharma

Glenmark Pharmaceuticals, a global pharmaceutical company, yesterday announced it has entered into a development, license, manufacture and commercial supply agreement with Spanish company Cyndea Pharma S.L.

Glenmark made a licensing agreement with APC Therapeutics

Glenmark Pharmaceuticals informed it has entered into an agreement with Boston‐based biopharmaceutical firm APC Therapeutics to in-license the latter’s novel immune-oncology molecule

Glenmark obtained FDA approval for hypertension drug

Glenmark Pharmaceuticals stated in a regulatory filing that it received final FDA approval for its generic version of Forest Laboratories' hypertension treatment Bystolic

FDA approved Glenmark’s generic drug

fda office
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (FDA) for fenofibrate capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor...